Literature DB >> 7883421

Reliability of tumor typing of endometrial carcinoma in prehysterectomy curettage.

B Lampe1, R Kürzl, P Hantschmann.   

Abstract

The aim of this study was to determine the sensitivity and the specificity of tumor typing in the prehysterectomy curettage in order to assess the diagnostic accuracy in patients with endometrial cancer. Tumor typing was performed on complete prehysterectomy curettages of 154 patients with endometrial cancer treated during 1987-1991. The results were compared with the histologic findings of the hysterectomy specimen as the gold standard. Patients with no carcinoma demonstrable postoperatively in the removed uterus were excluded from the study. Tumor typing on prehysterectomy curettage revealed only a moderate sensitivity of 46-64%. In contrast, the specificity was > 90% for all histologic subtypes with the exception of the endometrioid tumor type (68%). The histologic subtypes (papillary, adenocarcinoma with squamous differentiation, mucinous, serous papillary, clear cell) achieved similar high predictive values despite a much lower prevalence due to the high values of specificity. Tumor typing of endometrial carcinoma based upon the findings of the prehysterectomy curettage reveals different reliabilities depending on the tumor type.

Entities:  

Mesh:

Year:  1995        PMID: 7883421     DOI: 10.1097/00004347-199501000-00002

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  2 in total

1.  Invasive endometrial lesion in a patient with mental retardation.

Authors:  Jonathan Oh; Mala Karunanayake; C Allen Stringer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

2.  Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.

Authors:  Ingvild L Tangen; Reidun K Kopperud; Nicole Cm Visser; Anne C Staff; Solveig Tingulstad; Janusz Marcickiewicz; Frédéric Amant; Line Bjørge; Johanna Ma Pijnenborg; Helga B Salvesen; Henrica Mj Werner; Jone Trovik; Camilla Krakstad
Journal:  Br J Cancer       Date:  2017-07-27       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.